Esposito S et al
The parenteral segment dominated the market while holding the largest share of 88% in 2025 because injectable formulations provide precise dosing, rapid absorption, and sustained therapeutic effects, which are critical for achieving effective weight loss and glycemic control
Full-Pathway Inhibition: Whether the product can brighten across three dimensions: inhibiting tyrosinase, blocking melanin transport, and accelerating metabolism
-Contains glutathione and low-molecular collagen
Coates, P.M., Blackman, M.R., Cragg, G.M., Levine, M., Moss, J., White, J.D
Yes, when administered by qualified medical professionals following a medical assessment